Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Southern Denmark
With
Odense University Hospital
National Tuberculosis Control Programme, Ghana
Odense Patient Data Explorative Network
University of Ghana
Tema General Hospital, Ghana
Lekma Hospital, Ghana
Korle-Bu Teaching Hospital, Ghana
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
HIV-positive
18 years and above
Able to give informed consent
Admitted at the wards attached to the research site ART/HIV-clinic
Eligible for LF-LAM testing (defined by WHO in the LF-LAM policy update 2019): CD4-cell-count ≤200 cells/μL (the last measured CD4-cell-count); or a WHO clinical stage 3 or 4 event at presentation for care; or seriously ill defined by WHO (respiratory rate \> 30/min, temperature \> 39°C, heart rate \> 120/min or unable to walk unaided); or a positive WHO TB symptom screening including one of the following symptoms: current cough, fever, weight loss, or night sweats
You may not be if
Anti-tuberculous treatment including preventive treatment with Isoniazide within the last 60 days
Earlier participation in the same study
Clareo Health | POC Strategies to Improve TB Care in Advanced HIV Disease
